Enquire now and stand a chance to win exclusive gifts!
Enquire now and stand a chance to win exclusive gifts!
Enquire now and stand a chance to win exclusive gifts!
Enquire now and stand a chance to win exclusive gifts!
Enquire now and stand a chance to win exclusive gifts!
Enquire now and stand a chance to win exclusive gifts!

Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

WuXi ATU and GeneMedicine Sign Development and Manufacturing Agreement for Oncolytic Virus Products

Friday, November 29, 2019

WuXi ATU Co Ltd a subsidiary of WuXi AppTec and GeneMedicine a South Koreabased gene therapy biotechnology company have formed a strategic partnership for the development and manufacturing of oncolytic virus products Under the terms of the collabor...

Verrica Pharmaceuticals Announces FDA Filing Acceptance of New Drug Application for VP-102

Thursday, November 28, 2019

Verrica Pharmaceuticals Inc a medical dermatology company today announced that its New Drug Application NDA for VP cantharidin Topical Solution a proprietary topical therapy for the treatment of molluscum contagiosum molluscum has been accepted for...

Lonza and DiNAQOR AG Announce Strategic Collaboration to Advance Gene Therapy Programs for Patients with Monogenic Cardiomyopathies

Wednesday, November 27, 2019

Lonza and DiNAQOR AG a global gene therapy platform company today announced a strategic collaboration to advance DiNAQORs preclinical programs for the treatment of cardiac myosinbinding proteinC MYBPC cardiomyopathies a genetic condition that can res...

Hoth Therapeutics and North Carolina State University Enter License Agreement for Gene Therapy

Wednesday, November 27, 2019

Hoth Therapeutics Inc a biopharmaceutical company focused on developing new generation therapies for dermatological disorders such as atopic dermatitis chronic wounds psoriasis and acne today announced it has entered into a licensing agreement with...

Ardelyx and Kyowa Kirin Expand Partnership with Two Additional Agreements

Tuesday, November 26, 2019

Ardelyx Inc a specialized biopharmaceutical company focused on developing firstinclass medicines to improve treatment for people with cardiorenal diseases and Kyowa Kirin Co Ltd TSE President and CEO Masashi Miyamoto Kyowa Kirin a Japanbased Global S...

Alkermes Completes Acquisition of Rodin Therapeutics

Tuesday, November 26, 2019

Alkermes plc today announced that it has completed its previously announced acquisition of Rodin Therapeutics Inc Rodin a privately held biopharmaceutical company This transaction builds on Alkermes experience in central nervous system CNS diseases a...

FDA Grants Priority Review to Genentech’s Risdiplam for Spinal Muscular Atrophy

Monday, November 25, 2019

Genentech a member of the Roche Group today announced that the US Food and Drug Administration FDA has accepted the New Drug Application NDA and granted Priority Review for risdiplam an investigational survival motor neuron SMN splicing modifier for...

Onconova Therapeutics Announces Exclusive License Agreement with Knight Therapeutics

Friday, November 22, 2019

Onconova Therapeutics Inc a Phase stage biopharmaceutical company discovering and developing novel products to treat cancer with a focus on myelodysplastic syndromes MDS today announced they have entered into a Distribution License and Supply Agreeme...

Phenomics Health Inc. acquires patented drug metabolome technology

Friday, November 22, 2019

Phenomics Health Inc a precision medicine company based on the bioinformatics platform today announced that it has acquired Precera Bioscience based in Franklin Tennessee USA Patented drug metabolome technology portfolio

Dragonfly Therapeutics Announces Collaboration with AbbVie for Autoimmune Diseases and Oncology

Thursday, November 21, 2019

Dragonfly Therapeutics Dragonfly a biotechnology company developing novel immunotherapies that harness the innate immune system to treat disease and AbbVie NYSE ABBV a researchbased global biopharmaceutical company today announced a multitarget resea...

Latest Issue
Get instant
access to our latest e-book